Newman Mary
SVP, Regulatory Affairs at Audentes Therapeutics, Inc.
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jun 25, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Audentes Therapeutics, Inc.SVP, Regulatory Affairs
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Audentes Therapeutics, Inc.UnusualAug 24, 2017 2017
Sold 10,000 shares at $20.00 ($200k)
Newman Mary, SVP, Regulatory Affairs
Sold 100% of holdings ($200k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Audentes Therapeutics, Inc.UnusualNov 16, 2017 +84 days
Sold 10,000 shares at $26.84 ($268k)
Newman Mary, SVP, Regulatory Affairs
Sold 100% of holdings ($268k position)0 shares leftFiling
- 3 Form 4 sale Audentes Therapeutics, Inc.UnusualMar 15, 2018 +119 days
Sold 10,000 shares at $30.36 ($304k)
Newman Mary, SVP, Regulatory Affairs
Sold 100% of holdings ($304k position)0 shares leftFiling
- 4 Form 4 sale Audentes Therapeutics, Inc.UnusualJun 25, 2018 +102 days
Sold 8,545 shares at $40.79 ($349k)
Newman Mary, SVP, Regulatory Affairs
Sold 100% of holdings ($349k position)0 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2018 | Jun 27, 2018 | Audentes Therapeutics, Inc. | SVP, Regulatory Affairs | Form 4 sale | 8,545 | $349k | 100.0% | Unusual | SEC |
| Mar 15, 2018 | Apr 2, 2018 | Audentes Therapeutics, Inc. | SVP, Regulatory Affairs | Form 4 sale | 10,000 | $304k | 100.0% | Unusual | SEC |
| Nov 16, 2017 | Nov 17, 2017 | Audentes Therapeutics, Inc. | SVP, Regulatory Affairs | Form 4 sale | 10,000 | $268k | 100.0% | Unusual | SEC |
| Aug 24, 2017 | Aug 25, 2017 | Audentes Therapeutics, Inc. | SVP, Regulatory Affairs | Form 4 sale | 10,000 | $200k | 100.0% | Unusual | SEC |